Elanix Biotechnologies AG | Balance Sheet
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
Cash & Short Term Investments
13.20
33.70
72.80
73.60
212.20
Total Accounts Receivable
-
-
86.10
70.50
914.00
Inventories
-
-
-
33.50
138.70
Other Current Assets
0.40
0.10
-
-
-
Total Current Assets
13.60
33.70
158.90
177.60
1,264.90
Net Property, Plant & Equipment
-
-
0.50
15.20
39.70
Total Investments and Advances
275.00
280.00
-
-
-
Intangible Assets
-
-
22,455.90
21,341.80
20,093.90
Total Assets
288.60
313.70
22,749.60
21,806.10
22,420.90
Accounts Payable
0.80
-
76.50
250.30
576.50
Other Current Liabilities
-
35.80
634.20
758.30
1,080.30
Total Current Liabilities
0.80
35.80
710.70
1,008.60
1,656.70
Provision for Risks & Charges
5.50
15.00
-
-
-
Deferred Taxes
-
-
5,030.60
4,576.80
3,538.90
Other Liabilities
-
-
797.20
515.10
168.40
Total Liabilities
6.30
50.80
6,672.70
6,372.00
6,386.50
Common Equity (Total)
282.30
262.90
16,076.90
15,434.00
16,034.50
Total Shareholders' Equity
282.30
262.90
16,076.90
15,434.00
16,034.50
Total Equity
282.30
262.90
16,076.90
15,434.00
16,034.50
Liabilities & Shareholders' Equity
288.60
313.70
22,749.60
21,806.10
22,420.90
About Elanix Biotechnologies
View Profile
